Tower Research Capital »

Context Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.8k 6.4k 1.38
2023-09-30 $14k 9.0k 1.51
2023-06-30 $9.5k 5.9k 1.60
2023-03-31 $5.0k 8.8k 0.57
2022-12-31 $6.0k 8.9k 0.68
2022-09-30 $8.0k 7.3k 1.10
2022-06-30 $6.0k 3.0k 2.02
2022-03-31 $0 33 0.00
2021-12-31 $5.8k 2.1k 2.81